Abnormal platelet function in Chediak-Higashi syndrome.

Genetic defects in Chediak-Higashi syndrome and the beige mouse. J Clin Immunol (1998) 1.05

Turnover of kidney beta-glucuronidase in normal and Chédiak-Higashi (beige) mice. Am J Pathol (1978) 0.88

Evidence that abnormal platelet functions in human Chédiak-Higashi syndrome are the result of a lack of dense bodies. Am J Pathol (1983) 0.81

Ultrastructure of resting and activated storage pool deficient platelets from animals with the Chédiak-Higashi syndrome. Am J Pathol (1982) 0.81

Specific correction of impaired acid hydrolase secretion in storage pool-deficient platelets by adenosine diphosphate. J Clin Invest (1988) 0.80

The role of superoxide anion generation in phagocytic bactericidal activity. Studies with normal and chronic granulomatous disease leukocytes. J Clin Invest (1975) 7.40

Quantitative nitroblue tetrazolium test in chronic granulomatous disease. N Engl J Med (1968) 6.91

Cloning the gene for an inherited human disorder--chronic granulomatous disease--on the basis of its chromosomal location. Nature (1986) 6.34

Leukocyte oxidase: defective activity in chronic granulomatous disease. Science (1967) 4.25

Mutations in the gene encoding neutrophil elastase in congenital and cyclic neutropenia. Blood (2000) 3.45

Degranulation of leukocytes in chronic granulomatous disease. J Clin Invest (1969) 3.17

Respiration and glucose oxidation in human and guinea pig leukocytes: comparative studies. J Clin Invest (1970) 2.83

The biochemical basis of nitroblue tetrazolium reduction in normal human and chronic granulomatous disease polymorphonuclear leukocytes. Blood (1976) 2.76

Deficiency of reduced nicotinamide-adenine dinucleotide oxidase in chronic granulomatous disease. Science (1968) 2.56

The role of superoxide anion and hydrogen peroxide in phagocytosis-associated oxidative metabolic reactions. J Clin Invest (1975) 2.40

Disorders of phagocytic cell function. Prog Hematol (1971) 2.37

Neutrophil action dysfunction and abnormal neutrophil behavior. N Engl J Med (1974) 2.35

The selectivity of the thrombin-induced platelet release reaction: subcellular localization of released and retained constituents. J Lab Clin Med (1970) 2.13

Failure of nitro blue tetrazolium reduction in the phagocytic vacuoles of leukocytes in chronic granulomatous disease. J Clin Invest (1969) 2.11

Autooxidation as a basis for altered function by polymorphonuclear leukocytes. Blood (1977) 2.10

Microdetermination of adenosine diphosphate and adenosine triphosphate in plasma with firefly luciferase system. Anal Biochem (1966) 2.07

Determination of ATP and ADP in blood platelets: a modification of the firefly luciferase assay for plasma. Anal Biochem (1972) 2.05

Correction of metabolic deficiencies in the leukocytes of patients with chronic granulomatous disease. J Clin Invest (1970) 2.04

Regulation of interleukin 8 gene expression by oxidant stress. J Biol Chem (1993) 2.02

Thrombospondin binds to Staphylococcus aureus and promotes staphylococcal adherence to surfaces. Infect Immun (1991) 1.99

Monocyte function in children with neutropenia and chronic infections. Blood (1972) 1.98

Improvement of leukocyte bactericidal activity in chronic granulomatous disease. Blood (1970) 1.90

The blood platelet release reaction. Scand J Haematol Suppl (1969) 1.87

Complete deficiency of leukocyte glucose-6-phosphate dehydrogenase with defective bactericidal activity. J Clin Invest (1972) 1.85

Chronic granulomatous disease: correlation between pathogenesis and clinical findings. Pediatrics (1971) 1.76

Endotoxin enhances tissue factor and suppresses thrombomodulin expression of human vascular endothelium in vitro. J Clin Invest (1987) 1.74

Oxidant injury of caucasian glucose-6-phosphate dehydrogenase-deficient red blood cells by phagocytosing leukocytes during infection. J Clin Invest (1971) 1.72

Benign and malignant teratomas in children: analysis of 85 patients. Surgery (1976) 1.71

Microbicidal/cytotoxic proteins of neutrophils are deficient in two disorders: Chediak-Higashi syndrome and "specific" granule deficiency. J Clin Invest (1988) 1.63

Lactoferrin: a promoter of polymorphonuclear leukocyte adhesiveness. Blood (1981) 1.57

Adenine nucleotide metabolism of blood platelets. VI. Subcellular localization of nucleotide pools with different functions in the platelet release reaction. Biochim Biophys Acta (1969) 1.54

Myelodysplasia syndrome and acute myeloid leukemia in patients with congenital neutropenia receiving G-CSF therapy. Blood (2000) 1.54

Correction of leukocyte function in Chediak-Higashi syndrome by ascorbate. N Engl J Med (1976) 1.52

Secretable storage pools in platelets. Annu Rev Med (1979) 1.49

Platelet release reaction during clotting of native human platelet-rich plasma. Proc Soc Exp Biol Med (1972) 1.44

Metabolic and bactericidal activities of human eosinophils. Br J Haematol (1971) 1.41

Studies on gel-filtered human platelets: isolation and characterization in a medium containing no added Ca2+, Mg2+, or K+. J Lab Clin Med (1975) 1.36

Evidence that neomycin inhibits binding of herpes simplex virus type 1 to the cellular receptor. J Virol (1987) 1.36

Interaction of polylysine with the cellular receptor for herpes simplex virus type 1. J Gen Virol (1988) 1.35

Oxidant activity in expired breath of patients with adult respiratory distress syndrome. Lancet (1986) 1.34

Wiskott-Aldrich syndrome: qualitative platelet defects and short platelet survival. Br J Haematol (1969) 1.32

Effects of antimycin and 2-deoxyglucose on adenine nucleotides in human platelets. Role of metabolic adenosine triphosphate in primary aggregation, secondary aggregation and shape change of platetets. Biochem J (1974) 1.32

Differential energy requirements for platelet responses. A simultaneous study of aggregation, three secretory processes, arachidonate liberation, phosphatidylinositol breakdown and phosphatidate production. Biochem J (1982) 1.31

Interactions of actin, myosin, and an actin-binding protein of chronic myelogenous leukemia leukocytes. J Clin Invest (1976) 1.31

Effects of a chemotactic factor, N-formylmethionyl peptide, on adherence, superoxide anion generation, phagocytosis, and microtubule assembly of human polymorphonuclear leukocytes. J Lab Clin Med (1979) 1.30

Stable expression of a secretable deletion mutant of recombinant human thrombomodulin in mammalian cells. J Biol Chem (1990) 1.30

Concepts of the blood platelet release reaction. Ser Haematol (1971) 1.29

Thrombin-stimulated myosin phosphorylation in intact platelets and its possible involvement secretion. Thromb Haemost (1977) 1.28

The formation of ceramide-1-phosphate during neutrophil phagocytosis and its role in liposome fusion. J Biol Chem (1998) 1.27

DNA linkage analysis of X chromosome-linked chronic granulomatous disease. Proc Natl Acad Sci U S A (1986) 1.27

Actin cytoskeletal function is spared, but apoptosis is increased, in WAS patient hematopoietic cells. Blood (2000) 1.26

Comparative study of the metabolic and bactericidal characteristics of severely glucose-6-phosphate dehydrogenase-deficient polymorphonuclear leukocytes and leukocytes from children with chronic granulomatous disease. J Reticuloendothel Soc (1972) 1.25

Effects of moxalactam on blood coagulation and platelet function. Rev Infect Dis (1983) 1.24

Inhibition of polymorphonuclear leukocyte adherence by prostacyclin. J Lab Clin Med (1980) 1.24

Hereditary defect in the platelet release reaction caused by a deficiency in the storage pool of platelet adenine nucleotides. Br J Haematol (1970) 1.23

Tight coupling of thrombin-induced acid hydrolase secretion and phosphatidate synthesis to receptor occupancy in human platelets. Biochem J (1984) 1.23

Further evidence for a deficient storage pool of adenine nucleotides in platelets from some patients with thrombocytopathia--"storage pool disease". Blood (1972) 1.23

An outbreak of pneumocystis pneumonia in children with acute lymphocytic leukemia. Am J Dis Child (1978) 1.22

In vitro inhibition of granulopoiesis by 4-amino-4'-hydroxylaminodiphenyl sulfone. Br J Haematol (1980) 1.21

Metabolic, membrane, and functional responses of human polymorphonuclear leukocytes to platelet-activating factor. Blood (1982) 1.20

Thrombospondin stimulates motility of human neutrophils. J Cell Biol (1990) 1.20

Platelet-derived growth factor promotes human peripheral monocyte activation. Blood (1985) 1.19

Phagocytosis of neutrophils by marrow macrophages in childhood chronic benign neutropenia. J Pediatr (1981) 1.19

Lactoferrin deficiency associated with altered granulocyte function. N Engl J Med (1982) 1.17

Effect of alpha-2 glycoprotein on the immune response. Transplantation (1965) 1.17

Functions of human monocyte and lymphocyte subsets obtained by countercurrent centrifugal elutriation: differing functional capacities of human monocyte subsets. J Immunol (1981) 1.16

Subcellular particles of human platelets. A biochemical and electron microscopic study with particular reference to the influence of fractionation techniques. Scand J Haematol Suppl (1969) 1.15

Adenine nucleotide metabolism of blood platelets. 3. Adenine phosphoribosyl transferase and nucleotide formation from exogenous adenine. Biochim Biophys Acta (1968) 1.15

Monocyte aggregation and superoxide anion release in response to formyl-methionyl-leucyl-phenylalanine (FMLP) and platelet-activating factor (PAF). J Immunol (1982) 1.15

Myosin phosphorylation in intact platelets. J Biol Chem (1981) 1.14

Interrelationships among platelet responses: studies on the burst in proton liberation, lactate production, and oxygen uptake during platelet aggregation and Ca2+ secretion. Blood (1981) 1.14

Association between gelatinase release and increased plasma membrane expression of the Mo1 glycoprotein. Blood (1987) 1.14

Volume of the spleen in children as measured on CT scans: normal standards as a function of body weight. AJR Am J Roentgenol (1993) 1.13

Purified human plasma kallikrein aggregates human blood neutrophils. J Clin Invest (1982) 1.13

Diminished polymorphonuclear leukocyte adherence. Function dependent on release of cyclic AMP by endothelial cells after stimulation of beta-receptors by epinephrine. J Clin Invest (1980) 1.13

Lipid peroxidation in the killing of phagocytized pneumococci. Infect Immun (1974) 1.13

Favorable prognosis for survival in children with coincident opso-myoclonus and neuroblastoma. Cancer (1976) 1.12

Adenine nucleotide metabolism of blood platelets. IV. Platelet aggregation response to exogenous ATP and ADP. Biochim Biophys Acta (1968) 1.12

Hydrogen peroxide lowers ATP levels in platelets without altering adenyalte energy charge and platelet function. J Biol Chem (1977) 1.12

Neutropenia induced by systemic infusion of lactoferrin. J Lab Clin Med (1982) 1.11

The alteration of superoxide dismutase, catalase, glutathione peroxidase, and NAD(P)H cytochrome c reductase in guinea pig polymorphonuclear leukocytes and alveolar macrophages during hyperoxia. J Clin Invest (1976) 1.10

The effect of 2-deoxyglucose on guinea pig polymorphonuclear leukocyte phagocytosis. J Cell Physiol (1977) 1.10

Autoimmune neutropenia. N Engl J Med (1975) 1.10

Phorbol diesters stimulate the development of an early murine progenitor cell. The burst-forming unit-megakaryocyte. J Clin Invest (1985) 1.10

Septicemia and meningitis in children splenectomized for hodgkin's disease. N Engl J Med (1976) 1.10